top of page
Search

Derm Therapeutics for MRCP Part 1: Steroids & Retinoids

TL;DR

For MRCP Part 1, dermatology therapeutics frequently focuses on topical corticosteroids and retinoids, particularly their indications, potency classes, and adverse effects. These drug classes appear repeatedly in pharmacology and dermatology questions because they illustrate core concepts such as drug selection, contraindications, and complications. This guide summarises the most tested steroid and retinoid facts, provides a mini-case, and includes practical revision tips for MRCP candidates.


Derm Therapeutics: Steroids & Retinoids — MRCP Part 1 High-Yield Guide

Dermatology questions in MRCP Part 1 often test treatment principles rather than obscure disease mechanisms. In particular, topical corticosteroids and retinoids are repeatedly examined because they underpin management of common conditions such as acne, eczema, and psoriasis.

Candidates preparing for the exam should recognise:

  • When steroids are first-line therapy

  • When retinoids are preferred

  • Which adverse effects are classically tested

  • Situations where these drugs are contraindicated

If you are revising the dermatology section of the exam syllabus, reviewing the MRCP Part 1 overview can help structure your preparation and identify the most important topics.


Why Dermatology Therapeutics Matters in MRCP Part 1

Dermatology contributes a relatively small proportion of exam questions, but therapeutics questions are high-yield and predictable.

Examiners frequently test:

  1. Correct drug of choice

  2. Mechanism of action

  3. Adverse effects

  4. Contraindications

  5. Clinical decision making

Understanding how dermatological drugs work also helps answer questions across multiple disciplines, including immunology, pharmacology, and internal medicine.

For structured practice questions covering these topics, many candidates use a dedicated MRCP question bank to reinforce exam patterns.


High-Yield Steroid Concepts for MRCP Part 1

Topical corticosteroids are among the most frequently prescribed dermatology medications, and exam questions often revolve around their potency classification and safe use.


Topical corticosteroid potency classes

Potency

Example

Typical clinical use

Mild

Hydrocortisone

Face, flexures, children

Moderate

Clobetasone butyrate

Mild eczema

Potent

Betamethasone valerate

Psoriasis plaques

Very potent

Clobetasol propionate

Severe psoriasis, lichen planus

Key exam point: Very potent steroids should not be used on the face due to risk of skin atrophy and telangiectasia.

A useful overview of steroid potency and indications is provided by the British Association of Dermatologists:https://www.bad.org.uk/pils/topical-corticosteroids/

Common indications for topical steroids

Steroids are used to control inflammation in many dermatological conditions, including:

  • Atopic eczema

  • Contact dermatitis

  • Psoriasis

  • Lichen planus

  • Discoid lupus erythematosus

However, they are not appropriate for untreated infections, particularly fungal infections such as tinea.


Classic adverse effects of topical steroids

MRCP questions frequently describe complications of chronic steroid use.

Important adverse effects include:

  • Skin atrophy

  • Striae

  • Telangiectasia

  • Perioral dermatitis

  • Acneiform eruptions

Long-term use of potent steroids can also cause systemic absorption, especially when applied over large areas.

Further clinical guidance on topical steroid safety can be found in NICE Clinical Knowledge Summaries:https://cks.nice.org.uk/topics/eczema-atopic/management/topical-corticosteroids/


Retinoids: Mechanisms and Clinical Use

Retinoids are vitamin A derivatives that regulate epithelial cell growth and differentiation. They are particularly important in acne management.

Key actions include:

  • Reducing sebaceous gland activity

  • Normalising keratinisation

  • Preventing comedone formation

  • Anti-inflammatory effects

Because of these properties, retinoids are central to acne treatment algorithms.

A comprehensive pharmacology overview is available from StatPearls (NCBI):https://www.ncbi.nlm.nih.gov/books/NBK482509/


Topical Retinoids in Acne

Common topical retinoids include:

  • Tretinoin

  • Adapalene

  • Tazarotene

These medications are most effective for comedonal acne and are often combined with other agents such as benzoyl peroxide.

Common side effects

Topical retinoids frequently cause:

  • Skin irritation

  • Dryness

  • Photosensitivity

  • Mild erythema

Patients are usually advised to apply retinoids at night and use sunscreen during the day.

The NICE acne management guideline discusses these therapies in detail:https://www.nice.org.uk/guidance/ng198


Oral Isotretinoin: A Classic Exam Drug

Isotretinoin is the most effective therapy for severe nodulocystic acne.

It works by:

  • Dramatically reducing sebaceous gland size

  • Decreasing sebum production

  • Normalising follicular keratinisation

In many patients, isotretinoin can produce long-term remission.

However, it also has important risks.

Key adverse effects of isotretinoin

Adverse effects frequently tested in MRCP questions include:

  • Teratogenicity

  • Dry skin and cheilitis

  • Elevated triglycerides

  • Raised liver enzymes

  • Mood changes (rare but exam-relevant)

Because of its teratogenic potential, strict pregnancy prevention programmes are used during therapy.

A detailed safety overview is available from the British National Formulary:https://bnf.nice.org.uk/drugs/isotretinoin/


Retinoids in Psoriasis

Retinoids also have an important role in psoriasis treatment.

The oral retinoid acitretin is used for:

  • Severe plaque psoriasis

  • Pustular psoriasis

  • Palmoplantar psoriasis

Acitretin works by normalising keratinocyte differentiation and proliferation.

Guidelines from the American Academy of Dermatology discuss retinoid therapy in psoriasis:https://www.aad.org/member/clinical-quality/guidelines/psoriasis


Five Most Tested Subtopics in Dermatology Therapeutics

For MRCP Part 1, the following subtopics appear repeatedly:

  1. Steroid potency classification

  2. Steroid adverse effects

  3. Isotretinoin indications

  4. Retinoid teratogenicity

  5. Acne treatment algorithms

These topics are frequently integrated into clinical scenarios rather than direct recall questions, so understanding the reasoning behind treatment choices is crucial.


Mini-Case (MRCP Style)

A 21-year-old woman presents with severe nodulocystic acne affecting her face and trunk. She has previously tried topical benzoyl peroxide and oral antibiotics with minimal improvement.

Which treatment is most appropriate?

A. Hydrocortisone creamB. Adapalene gelC. IsotretinoinD. MethotrexateE. Acitretin

Answer: C — Isotretinoin

Explanation

Isotretinoin is the drug of choice for severe nodulocystic acne that has not responded to conventional therapies. It significantly reduces sebaceous gland activity and improves severe inflammatory acne. However, due to high teratogenic risk, strict pregnancy prevention measures are mandatory during treatment.


Five Common MRCP Traps

Candidates frequently lose marks because of the following misconceptions:

  • Using potent steroids on the face, increasing risk of skin atrophy

  • Confusing acitretin and isotretinoin indications

  • Forgetting retinoid teratogenicity

  • Treating fungal infections with topical steroids alone

  • Assuming antibiotics are always first-line for acne

Recognising these traps is essential when answering clinical scenario questions.


Doctor revising dermatology pharmacology notes for MRCP Part 1

Practical Study-Tip Checklist

Use this checklist when revising dermatology therapeutics for MRCP Part 1:

  1. Memorise the four steroid potency classes

  2. Learn which body sites require mild steroids

  3. Review classic steroid adverse effects

  4. Understand the mechanism of retinoids

  5. Know the indications for isotretinoin

  6. Revise retinoid teratogenicity rules

  7. Distinguish acne vs eczema treatments

  8. Review psoriasis treatment hierarchy

  9. Practise exam questions regularly

  10. Analyse mistakes after each mock test

Timed assessments such as a mock MRCP exam can help simulate exam pressure and improve recall.


FAQs

Which dermatology drugs are most tested in MRCP Part 1?

Topical corticosteroids and retinoids are among the most frequently examined dermatology drugs. Questions often focus on potency classes, indications, and adverse effects.

Why is isotretinoin important for MRCP Part 1?

Isotretinoin is a key exam drug because it treats severe acne and has distinctive adverse effects such as teratogenicity and hyperlipidaemia.

What steroid potency should be used on the face?

Mild steroids such as hydrocortisone are preferred for the face to reduce the risk of skin atrophy and telangiectasia.

Are retinoids used in psoriasis?

Yes. The oral retinoid acitretin is used for severe psoriasis and disorders of keratinisation.

How should I revise dermatology for MRCP Part 1?

Focus on common drugs, mechanisms, adverse effects, and indications. Regular practice with MCQs and mock exams helps consolidate these concepts.


Ready to start?

Mastering dermatology therapeutics requires repeated exposure to exam-style questions. Start practising with the Free MRCP MCQs and test your readiness with a mock MRCP exam.


Sources

  1. MRCP(UK) Examination Blueprinthttps://www.mrcpuk.org/mrcpuk-examinations/part-1

  2. British Association of Dermatologists – Topical corticosteroidshttps://www.bad.org.uk/pils/topical-corticosteroids/

  3. NICE Acne Guidelinehttps://www.nice.org.uk/guidance/ng198

  4. BNF – Isotretinoinhttps://bnf.nice.org.uk/drugs/isotretinoin/

  5. StatPearls – Retinoidshttps://www.ncbi.nlm.nih.gov/books/NBK482509/

 
 
 

Comments

bottom of page